N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
Kon Ken Wong,1,2 Shaun Wen Huey Lee,3– 6 Kok Pim Kua7 1Department of Microbiology and Immunology, Hospital Canselor Tuanku Muhriz UKM, Cheras, Kuala Lumpur, Malaysia; 2Faculty of Medicine, The National University of Malaysia, Cheras, Kuala Lumpur, Malaysia; 3School of Pharmacy, Monash University, Ba...
Guardado en:
Autores principales: | Wong KK, Lee SWH, Kua KP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eec9336dd064b7ea745524ad9264fa9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (COVID-19)
por: Hatem A Hejaz
Publicado: (2020) -
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Behnam Amani, et al.
Publicado: (2021) -
Desinfección de Alicates de Ortodoncia. Actualización de Recomendaciones en Contexto de COVID- 19. Revisión de la Literatura
por: Munizaga-Naveillan,María Soledad, et al.
Publicado: (2021) -
Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
por: Ruby A. Escobedo, et al.
Publicado: (2021) -
Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
por: Hertanto DM, et al.
Publicado: (2021)